BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11103814)

  • 21. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
    Peng G; Dixon DA; Muga SJ; Smith TJ; Wargovich MJ
    Mol Carcinog; 2006 May; 45(5):309-19. PubMed ID: 16508969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transduction pathways: targets for green and black tea polyphenols.
    Park AM; Dong Z
    J Biochem Mol Biol; 2003 Jan; 36(1):66-77. PubMed ID: 12542977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.
    Bottone FG; Martinez JM; Alston-Mills B; Eling TE
    Carcinogenesis; 2004 Mar; 25(3):349-57. PubMed ID: 14633654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
    Levitt RJ; Buckley J; Blouin MJ; Schaub B; Triche TJ; Pollak M
    Biochem Biophys Res Commun; 2004 Apr; 316(2):421-8. PubMed ID: 15020235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
    Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
    Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
    Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
    Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
    J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
    Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies with black tea and its constituents on leukemic cells and cell lines.
    Das M; Chaudhuri T; Goswami SK; Murmu N; Gomes A; Mitra S; Besra SE; Sur P; Vedasiromoni JR
    J Exp Clin Cancer Res; 2002 Dec; 21(4):563-8. PubMed ID: 12636103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways.
    Gao Y; Li W; Jia L; Li B; Chen YC; Tu Y
    Biochem Biophys Res Commun; 2013 Aug; 438(2):370-4. PubMed ID: 23892041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro cytotoxicity of a theaflavin mixture from black tea to malignant, immortalized, and normal cells from the human oral cavity.
    Babich H; Pinsky SM; Muskin ET; Zuckerbraun HL
    Toxicol In Vitro; 2006 Aug; 20(5):677-88. PubMed ID: 16297594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C; Blumenthal RD; Li H; Stein R; Goldenberg DM; Burton J
    Cancer Res; 2002 Apr; 62(7):2029-33. PubMed ID: 11929821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
    Uefuji K; Ichikura T; Shinomiya N; Mochizuki H
    Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.
    Li M; Song S; Lippman SM; Zhang XK; Liu X; Lotan R; Xu XC
    Oncogene; 2002 Jan; 21(3):411-8. PubMed ID: 11821953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Black tea theaflavins induce programmed cell death in cultured human stomach cancer cells.
    Hibasami H; Komiya T; Achiwa Y; Ohnishi K; Kojima T; Nakanishi K; Sugimoto Y; Hasegawa M; Akatsuka R; Hara Y
    Int J Mol Med; 1998 Apr; 1(4):725-7. PubMed ID: 9852288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; RosanĂ² L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.
    Subbarayan V; Sabichi AL; Llansa N; Lippman SM; Menter DG
    Cancer Res; 2001 Mar; 61(6):2720-6. PubMed ID: 11289153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.